Skip to Main Content

Author Details

Campbell Rogers
HeartFlow Inc.
1993
112
45
PMIDPaper TitleJournal TitlePublished Year
36828202Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial.Am Heart J2023
37192296Influence of Obesity on Coronary Artery Disease and Clinical Outcomes in the ADVANCE Registry.Circ Cardiovasc Imaging2023
34139187Enhanced Detection of Heart Valve Disease Using Integrated Artificial Intelligence at Scale.Ann Thorac Surg2022
36389264CMR findings in patients referred for suspected myocarditis following mRNA-based COVID vaccination compared with pre-COVID myocarditis referrals: A single-centre observational study.Int J Cardiol Heart Vasc2022
34953768The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.Am Heart J2022
35190274Coronary volume to left ventricular mass ratio in patients with diabetes mellitus.J Cardiovasc Comput Tomogr2022
34518113Trans-lesional fractional flow reserve gradient as derived from coronary CT improves patient management: ADVANCE registry.J Cardiovasc Comput Tomogr2022
34686567Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis.Heart2022
32418861Temporal changes in FFR<sub>CT</sub>-Guided Management of Coronary Artery Disease - Lessons from the ADVANCE Registry.J Cardiovasc Comput Tomogr2021
33656754Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography-based percutaneous intervention planner.Clin Cardiol2021
34722666Acute Stent-Induced Endothelial Denudation: Biomechanical Predictors of Vascular Injury.Front Cardiovasc Med2021
33032976The clinical utility of FFR<sub>CT</sub> stratified by age.J Cardiovasc Comput Tomogr2021
33454253Impact of an Interactive CT/FFR<sub>CT</sub> Interventional Planner on Coronary Artery Disease Management Decision Making.JACC Cardiovasc Imaging2021
310055401-Year Impact on Medical Practice and Clinical Outcomes of FFR<sub>CT</sub>: The ADVANCE Registry.JACC Cardiovasc Imaging2020
33693254Effect of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve on Physicians' Clinical Behaviorã¿¿- Differences Between Sites With and Without Appropriate Use Criteria as Designated by the Japanese Reimbursement System.Circ Rep2020
32102371Fractional Flow Reserve Derived from Coronary Computed Tomography Angiography Safely Defers Invasive Coronary Angiography in Patients with Stable Coronary Artery Disease.J Clin Med2020
33303435Safety and feasibility evaluation of planning and execution of surgical revascularisation solely based on coronary CTA and FFR<sub>CT</sub> in patients with complex coronary artery disease: study protocol of the FASTTRACK CABG study.BMJ Open2020
32861656Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCE.JACC Cardiovasc Imaging2020
32772465Coronary Computed Tomography Angiography Demonstrates a High Burden of Coronary Artery Disease Despite Low-Risk Nuclear Studies in Pre-Liver Transplant Evaluation.Liver Transpl2020
32883417Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review.J Am Coll Cardiol2020
30722688Predicting the Physiological Effect of Revascularization in Serially Diseased Coronary Arteries.Circ Cardiovasc Interv2019
31335283Determinants of Rejection Rate for Coronary CT Angiography Fractional Flow Reserve Analysis.Radiology2019
30996150Clinical Impact of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve on Japanese Population in the ADVANCE Registry.Circ J2019
29440200Impact of Coronary Remodeling on Fractional Flow Reserve.Circulation2018
30165613Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry.Eur Heart J2018
29422416Incidence and predictors of lesion-specific ischemia by FFR<sub>CT</sub>: Learnings from the international ADVANCE registry.J Cardiovasc Comput Tomogr2018
27973335Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial.EuroIntervention2017
28291726Change in angiogram-derived management strategy of patients with chest pain when some FFR data are available: How consistent is the effect?Cardiovasc Revasc Med2017
28674617An FFR<sub>CT</sub> diagnostic strategy versus usual care in patients with suspected coronary artery disease planned for invasive coronary angiography at German sites: one-year results of a subgroup analysis of the PLATFORM (Prospective Longitudinal Trial of FFR<sub>CT</sub>: Outcome and Resource Impacts) study.Open Heart2017
28699019The diagnostic performance of SPECT-MPI to predict functional significant coronary artery disease by fractional flow reserve derived from CCTA (FFR<sub>CT</sub>): sub-analysis from ACCURACY and VCT001 studies.Int J Cardiovasc Imaging2017
28017291Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFR<sub>CT</sub> in Coronary Care (ADVANCE) registry.J Cardiovasc Comput Tomogr2017
27581392Severe in-stent restenosis missed by coronary CT angiography and accurately detected with FFR<sub>CT</sub>.Int J Cardiovasc Imaging2017
274704491-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study.J Am Coll Cardiol2016
26329923Comparison Between Non-invasive (Coronary Computed Tomography Angiography Derived) and Invasive-Fractional Flow Reserve in Patients with Serial Stenoses Within One Coronary Artery: A NXT Trial substudy.Ann Biomed Eng2016
26475205Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM.J Am Coll Cardiol2015
26330417Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study.Eur Heart J2015
26385026Rationale and design of the Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts study.Am Heart J2015
22287299Control of cilostazol release kinetics and direction from a stent using a reservoir-based design.J Biomed Mater Res B Appl Biomater2012
22454106A nonelutable low-molecular weight heparin stent coating for improved thromboresistance.J Biomed Mater Res B Appl Biomater2012
21386089Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.Circ Cardiovasc Interv2011
20950809Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine.Atherosclerosis2010
21062998Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.Circ Cardiovasc Interv2010
22100684NEVOâ¿¢: a new generation of sirolimus-eluting coronary stent.EuroIntervention2009
18250270Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: an intravascular ultrasound and histopathology natural history study.Circulation2008
17268036Vulnerable plaque detection by temperature heterogeneity measured with a guidewire system: clinical, intravascular ultrasound and histopathologic correlates.J Invasive Cardiol2007
17919563The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.J Am Coll Cardiol2007
17630659Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularization.Catheter Cardiovasc Interv2007
16611760Multicenter evaluation of a self-expanding carotid stent system with distal protection in the treatment of carotid stenosis.AJNR Am J Neuroradiol2006
17126658Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach").Am J Cardiol2006
16754813Devices for distal protection during percutaneous coronary revascularization.Circulation2006
  • 1 - 50 of 112

Recommended Authors

Jeremy Kong
Kaiser Permanente San Francisco Medical Center
Career Start Year 2015
Number of shared co-authors 0
Michael S Levy
Comparative Effective Research Institute, Lahey Hospital and Medical Center
Career Start Year 2008
Number of shared co-authors 1
Qi Cheng
CVPath Institute
Career Start Year 2007
Number of shared co-authors 3
Michael S Aboodi
Montefiore Medical Center, Albert Einstein College of Medicine
Career Start Year 2005
Number of shared co-authors 1
Faisal Latif
SSM Health St. Anthony Hospital, University of Oklahoma
Career Start Year 2003
Number of shared co-authors 3
Klaus Tiroch
Switzerland Witten-Herdecke University
Career Start Year 2002
Number of shared co-authors 4
Paul M Grossman
University of Michigan ann arbor
Career Start Year 2000
Number of shared co-authors 1
Duane S Pinto
Beth Israel Deaconess Medical Center
Career Start Year 2000
Number of shared co-authors 7
Pinak B Shah
Brigham and Women's Hospital
Career Start Year 1997
Number of shared co-authors 9
Kreton Mavromatis
Atlanta VA Healthcare System
Career Start Year 1997
Number of shared co-authors 4
Marcella Calfon Press
David Geffen School of Medicine at university of california los angeles
Career Start Year 1996
Number of shared co-authors 2
Anthony A Bavry
Division of Cardiology University of Texas Southwestern Medical Center Dallas TX USA.
Career Start Year 1996
Number of shared co-authors 1
Ellen C Keeley
University of Florida
Career Start Year 1995
Number of shared co-authors 1
Thomas T Tsai
Institute for Health Research, Kaiser Permanente
Career Start Year 1993
Number of shared co-authors 6
William B Hillegass
University of Mississippi Medical Center
Career Start Year 1992
Number of shared co-authors 3
Issam Moussa
Carle Illinois College of Medicine, University of Illinois
Career Start Year 1992
Number of shared co-authors 6
Joaquin E Cigarroa
Oregon Health and Science University
Career Start Year 1991
Number of shared co-authors 2
Jesse W Currier
Veterans Affairs Greater Los Angeles Healthcare System
Career Start Year 1991
Number of shared co-authors 0
Kalon K L Ho
Beth Israel Deaconess Medical Center
Career Start Year 1990
Number of shared co-authors 7
Michael R Jaff
Boston Scientific Corporation
Career Start Year 1989
Number of shared co-authors 6
Malcolm R Bell
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 1
Scott A Berceli
University of Florida
Career Start Year 1989
Number of shared co-authors 0
Frank D Kolodgie
CVPath Institute
Career Start Year 1985
Number of shared co-authors 4
Richard E Shaw
California Pacific Medical Center
Career Start Year 1984
Number of shared co-authors 3
Daniel M Kolansky
University of Pennsylvania Perelman School of Medicine
Career Start Year 1982
Number of shared co-authors 2
David J Cohen
Clinical Trials Center, Cardiovascular Research Foundation
Career Start Year 1981
Number of shared co-authors 11
John C Messenger
University of Colorado Anschutz Medical Campus
Career Start Year 1978
Number of shared co-authors 8
James E Tcheng
Duke University
Career Start Year 1976
Number of shared co-authors 6
Igor F Palacios
Massachusetts General Hospital
Career Start Year 1976
Number of shared co-authors 6
Eric J Topol
Universidade Federal de Sao Paulo
Career Start Year 1975
Number of shared co-authors 4

Collaborators

Manesh R Patel
Duke Clinical Research Institute
Co-authored papers 20
Jeffrey J Popma
Harvard Medical School
Co-authored papers 14
Daniel I Simon
Case Western Reserve University
Co-authored papers 12
Pamela S Douglas
Duke Clinical Research Institute, Duke University
Co-authored papers 11
Mark A Hlatky
Co-authored papers 5
Frederic S Resnic
Lahey Hospital & Medical Center
Co-authored papers 4
Andrew P Selwyn
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Renu Virmani
CVPath Institute
Co-authored papers 3
Roxana Mehran
Co-authored papers 3
Laura Mauri
University of Milano
Co-authored papers 3
James E Udelson
Tufts Medical Center
Co-authored papers 2
Robert L Wilensky
Co-authored papers 2
Lucila Ohno-Machado
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers 2
Ron Waksman
Co-authored papers 2
Robert N Piana
Vanderbilt University Medical Center
Co-authored papers 2
Lucila Ohno-Machado
Co-authored papers 2
Matthew J Budoff
Lundquist Institute at Harbor university of california los angeles Medical Center
Co-authored papers 2
James M Kirshenbaum
Brigham and Women's Hospital
Co-authored papers 2
Marco V Wainstein
Universidade Federal do Rio Grande do Sul
Co-authored papers 2
Philip J Barter
Co-authored papers 1
Christopher B Liu
Co-authored papers 1
Christopher J White
Ochsner Clinical School, University of Queensland and Ochsner Health System
Co-authored papers 1
Aloke V Finn
CVPath Institute
Co-authored papers 1
Michael J Landzberg
Harvard Medical School
Co-authored papers 1
Rodrigo V Wainstein
Universidade Federal do Rio Grande do Sul
Co-authored papers 1
Christie M Ballantyne
Baylor College of Medicine
Co-authored papers 1
Nipun Arora
Carleton University.
Co-authored papers 1
Marcus Y Chen
and Blood Institute, National Institutes of Health
Co-authored papers 1
Kerry-Anne Rye
Co-authored papers 1
John A Spertus
University of Missouri-Kansas City School of Medicine
Co-authored papers 1
Release 1.2